Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

v3.21.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net loss $ (50,920) $ (33,989)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,117 3,624
Foreign exchange (gain) loss on long-term debt (8) 12
Bad debt expense 182
Gain on extinguishment of debt (2,096)
Change in fair value of warrants and derivatives (7,045) 1,756
Share-based compensation 2,150 1,482
Total adjustments (3,700) 6,874
Changes in operating assets and liabilities:    
Decrease in accounts receivable 18,001 7,480
(Increase) decrease in inventory (1,957) 4,679
(Increase) decrease in prepaid expenses and other current assets (452) 836
Decrease in other operating assets 6 86
(Decrease) in accounts payable (15,799) (6,238)
(Decrease) increase in deferred revenue (2,476) 568
Increase in other accrued expenses 5,599 483
Increase in other long-term liabilities 468 1,086
Increase in accrued interest on long-term debt 5,917 2,677
Net cash used in operating activities (45,313) (15,458)
Cash flows from investing activities:    
Purchase of property, plant and equipment (4,287) (1,159)
Net cash used in investing activities (4,287) (1,159)
Cash flows from financing activities:    
Repayments under line of credit, net (237)
Borrowings under other long-term debt 2,073
Proceeds from the Business Combination, issuance of convertible debt and PIPE financing, net of issuance costs paid 115,501
Proceeds from the exercise of stock options 78
Proceeds from the sale of Series G stock, net 21,913
Proceeds from the sale of Series H stock, net 505
Proceeds from the issuance of Series H warrants 142
Net cash provided by financing activities 116,226 23,749
Net increase in cash, cash equivalents and restricted cash 66,626 7,132
Cash, cash equivalents and restricted cash, beginning of year 18,618 3,013
Cash, cash equivalents and restricted cash, end of period 85,244 10,145
Supplemental disclosures of cash flow information    
Cash paid for interest 8,045 4,623
Cash paid for income taxes 552 394
Supplemental disclosure of non-cash financing activities:    
Reclassification of redeemable convertible preferred stock warrants to common stock 10,284
Non-cash net liabilities assumed from business combination $ 38